Utama › Sklerosis Berbilang Progresif Kronik › Ohio
Kajian klinikal Sklerosis Berbilang Progresif Kronik di Ohio
6 kajian untuk Sklerosis Berbilang Progresif Kronik sedang mencari peserta di lokasi di Ohio.
Bandar di Ohio
Teks kajian rasmi (Bahasa Inggeris)
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- The Ohio State University Wexner Medical Center (OSUWMC), Columbus
- The Boster Center for Multiple Sclerosis, Columbus
Mengambil pesertaFasa 3
Umur 18 hingga 60 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07299019A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 104, Columbus
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07840326A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- The Ohio State University Wexner Medical Center (OSUWMC) L3-100, Columbus
- The Boster Center for Multiple Sclerosis, Columbus
Mengambil pesertaFasa 3
Umur 18 hingga 60 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07067463Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- University of Cincinnati, Cincinnati
Mengambil pesertaFasa 1/2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07477639Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- University of Cincinnati (UC) Waddell Center for Multiple Sclerosis, Cincinnati
- Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland
Mengambil pesertaFasa 3
Umur 18 hingga 55 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT04047628Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
- Cleveland State University, Cleveland
Mengambil peserta
Umur 22 hingga 75 · Semua jantina · Dikemas kini 24 Sep 2025 · NCT05964829Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.